<?xml version="1.0" encoding="UTF-8"?>
<p id="JVEv5-para-0124">Approaches using gene editing to cure HBV infection are not as advanced as for HIV-1 therapy. Most studies, summarised at the Forum by Patrick Arbuthnot (University of the Witwatersrand, South Africa), have been based on preclinical evaluations.</p>
